Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Translate Bio, Inc. (TBIO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% | | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | | 171.2% |
| Gross profit | 100.0% | 100.0% | 100.0% | | -71.2% |
| Research and development | 79.0% | 978.6% | 4086.2% | | |
| General and administrative | 25.9% | 366.9% | 1592.0% | | 71.2% |
| EBITDA | -33.2% | -1185.0% | -7140.1% | | -166.5% |
| Depreciation | 6.7% | 60.6% | 200.1% | | 4.7% |
| EBIT | -39.8% | -1245.6% | -7340.1% | | -171.2% |
| Pre-tax income | -38.7% | -1458.0% | -7250.7% | | -170.5% |
| Income taxes | 0.0% | -6.2% | -391.9% | | 0.0% |
| Net income | -38.7% | -1451.7% | -6904.2% | | -0.2% |
|